作者: Ding-Guo Wu , Peng Yu , Jian-Wei Li , Peng Jiang , Jing Sun
DOI: 10.1016/J.TOXLET.2013.10.007
关键词: Growth inhibition 、 IκB kinase 、 Pancreatic cancer 、 Cell growth 、 Apigenin 、 Apoptosis 、 NFKB1 、 Cancer research 、 Biology 、 NF-κB
摘要: Apigenin is a potential chemopreventive agent for cancer prevention. Because of the central role transcription factor nuclear factor-κB (NF-κB) in pancreatic cancer, we investigated roles NF-κB apigenin-induced growth inhibition cells. It showed that apigenin reduced cell and induced apoptosis treatment down-regulated not only basal but also TNF-α-induced DNA binding activity, inhibitor κB (IκB)-α phosphorylation together with translocation p65 p50, it accompanied blockade IκB kinase (IKK)-β activity. Moreover, IKK blockage potentiated anticancer efficacy IKK-β overexpression attenuated inhibition. Additionally, (30 mg/kg) administration suppressed activation nude mice xenograft. These results indicated had to inhibit IKK-β-mediated activation, was valuable treatment.